cystine has been researched along with Alzheimer Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Dahlmanns, JK; Dahlmanns, M; Savaskan, N; Steiner, HH; Yakubov, E | 1 |
| Ashraf, A; Jeandriens, J; Parkes, HG; So, PW | 1 |
| Abe, K; Hishikawa, N; Huang, Y; Liu, X; Morihara, R; Ohta, Y; Sato, K; Shang, J; Shi, X; Takemoto, M; Yamashita, T | 2 |
| Brewer, GJ; Digman, MA; Dong, Y; Sameni, S | 1 |
| Inamura, K; Nagata, T; Nakayama, K; Nemoto, K; Shinagawa, S; Tagai, K; Tsuno, N | 1 |
| Brewer, GJ; Ghosh, D | 1 |
| Asselbergh, B; Bettens, K; Cruts, M; De Deyn, PP; Engelborghs, S; Heeman, B; Robberecht, C; Sleegers, K; Van Broeckhoven, C; Van Cauwenberghe, C; Vandenberghe, R; Vandenbulcke, M; Vermeulen, S | 1 |
| Albin, R; Banerjee, R; Garg, SK; Vitvitsky, V | 1 |
| Hellström-Lindahl, E; Mousavi, M; Nordberg, A; Ravid, R | 1 |
| Barger, SW | 1 |
| Coppedè, F; Lo Gerfo, A; Manca, ML; Mancuso, M; Migliore, L; Murri, L; Petrozzi, L; Siciliano, G | 1 |
| Beher, D; Beyreuther, K; Hesse, L; Masters, CL; Multhaup, G; Ruppert, T; Schlicksupp, A | 1 |
2 review(s) available for cystine and Alzheimer Disease
| Article | Year |
|---|---|
Glial Glutamate Transporter-Mediated Plasticity: System x
Topics: Alzheimer Disease; Amino Acid Transport System X-AG; Amino Acid Transport System y+; Amyotrophic Lateral Sclerosis; Antioxidants; Cystine; Glioma; Glutamic Acid; Humans; Microglia; Multiple Sclerosis; Parkinson Disease | 2023 |
An unconventional hypothesis of oxidation in Alzheimer's disease: intersections with excitotoxicity.
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cystine; Glutamates; Humans; Inflammation; Microglia; Neurons; Oxidation-Reduction; Oxidative Stress; Oxygen; Racemases and Epimerases; Respiratory Burst; Risk Factors; Serine | 2004 |
11 other study(ies) available for cystine and Alzheimer Disease
| Article | Year |
|---|---|
Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine/glutamate antiporter in Alzheimer's disease: Evidence of ferroptosis.
Topics: Alzheimer Disease; Antiporters; Cystine; Ferroptosis; Glutamic Acid; Humans; Iron; Lipid Peroxidation; Male | 2020 |
Clinical and Pathological Benefit of Twendee X in Alzheimer's Disease Transgenic Mice with Chronic Cerebral Hypoperfusion.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Behavior, Animal; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Cognition; Cystine; Dietary Supplements; Disease Models, Animal; Female; Glutamine; Inflammation Mediators; Male; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Mutation; Neuroprotective Agents; Oxidative Stress; Plaque, Amyloid | 2019 |
Reversibility of Age-related Oxidized Free NADH Redox States in Alzheimer's Disease Neurons by Imposed External Cys/CySS Redox Shifts.
Topics: Aging; Alzheimer Disease; Animals; Cell Nucleus; Cells, Cultured; Cellular Senescence; Cysteine; Cystine; Cytoplasm; Disease Models, Animal; Energy Metabolism; Female; Hippocampus; Humans; Intravital Microscopy; Male; Mice; Mice, Transgenic; Microscopy, Fluorescence; Mitochondria; NAD; Neurons; Oxidation-Reduction; Oxidative Stress; Primary Cell Culture | 2019 |
Twendee X Ameliorates Phosphorylated Tau, α-Synuclein and Neurovascular Dysfunction in Alzheimer's Disease Transgenic Mice With Chronic Cerebral Hypoperfusion.
Topics: alpha-Synuclein; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antioxidants; Ascorbic Acid; Brain; Cerebrovascular Disorders; Cystine; Dietary Supplements; Disease Models, Animal; Female; Genetic Predisposition to Disease; Glutamine; Male; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neurovascular Coupling; Phenotype; Phosphorylation; tau Proteins | 2019 |
Correlation between both morphologic and functional changes and anxiety in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anxiety; Brain; Cohort Studies; Cystine; Female; Gray Matter; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Neuropsychological Tests; Organ Size; Organotechnetium Compounds; Parietal Lobe; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2014 |
External cys/cySS redox state modification controls the intracellular redox state and neurodegeneration via Akt in aging and Alzheimer's disease mouse model neurons.
Topics: Aging; Alzheimer Disease; Animals; Cell Death; Cells, Cultured; Cysteine; Cystine; Disease Models, Animal; Extracellular Space; Glutathione; Male; Mice; Mice, Transgenic; NADP; Neurons; Oxidation-Reduction; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species | 2014 |
Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amino Acid Substitution; Belgium; Biological Transport; Clusterin; Cystine; Dimerization; Endoplasmic Reticulum; Exons; Female; Frameshift Mutation; Golgi Apparatus; HEK293 Cells; HeLa Cells; Humans; Male; Mutation, Missense; Protein Conformation; Recombinant Fusion Proteins; Transduction, Genetic; Transfection | 2015 |
Astrocytic redox remodeling by amyloid beta peptide.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Astrocytes; Cells, Cultured; Cystathionine beta-Synthase; Cysteine; Cystine; DNA; Dose-Response Relationship, Drug; Homeostasis; Humans; Mice; Mice, Inbred BALB C; Neurons; Oxidation-Reduction; Reactive Oxygen Species; tert-Butylhydroperoxide | 2011 |
Reduced levels of Abeta 40 and Abeta 42 in brains of smoking controls and Alzheimer's patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Binding Sites; Brain; Bridged Bicyclo Compounds, Heterocyclic; Bungarotoxins; Cystine; Down-Regulation; Humans; Iodine Radioisotopes; Middle Aged; Nicotine; Nicotinic Agonists; Peptide Fragments; Pyridines; Radioligand Assay; Receptors, Nicotinic; Smoking; Tritium | 2004 |
A Ser326Cys polymorphism in the DNA repair gene hOGG1 is not associated with sporadic Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amino Acid Substitution; Brain; Cystine; DNA Damage; DNA Glycosylases; DNA Mutational Analysis; DNA Repair; Female; Gene Frequency; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Male; Middle Aged; Mutation; Oxidative Stress; Polymorphism, Genetic; Serine | 2007 |
The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I)
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Binding Sites; Copper; Cysteine; Cystine; Electron Transport; Ferric Compounds; Histidine; Humans; Hydrogen Peroxide; Hydroxyl Radical; Mass Spectrometry; Oligopeptides; Oxidation-Reduction; Peptide Fragments; Recombinant Fusion Proteins; Superoxides | 1996 |